Hydrazone–Sulfonate Hybrids as Potential Cholinesterase Inhibitors: Design, Synthesis and Molecular Modeling Simulation

References

• Karran E , HardyJA. Critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer’s disease. Ann. Neurol.76, 185–205 (2014).
   PubMed Web of Science ®Google Scholar
• Long JM , HoltzmanDM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell179, 312–339 (2019).
   PubMed Web of Science ®Google Scholar
• Masters CL , BatemanR , BlennowK , RoweCC , SperlingRA , CummingsJL. Alzheimer’s disease. Nat. Rev. Dis. Primers1, 15056 (2015).
   PubMed Web of Science ®Google Scholar
• Musiek ES , HoltzmanDM. Three dimensions of the amyloid hypothesis: time, space and ‘wingmen’. Nat. Neurosci.18, 800–806 (2015).
   PubMed Web of Science ®Google Scholar
• Selkoe DJ , HardyJ. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol. Med.8, 595–608 (2016).
   PubMed Web of Science ®Google Scholar
• Tanzi RE , BertramL. Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell120, 545–555 (2005).
   PubMed Web of Science ®Google Scholar
• Brookmeyer R , JohnsonE , Ziegler-GrahamK , ArrighiHM. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement.3, 186–191 (2007).
   PubMed Web of Science ®Google Scholar
• Cummings JL , MorstorfT , ZhongK. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res. Ther.6, 37 (2014).
   PubMed Web of Science ®Google Scholar
• Holtzman DM , MorrisJC , GoateAM. Alzheimer’s disease: the challenge of the second century. Sci. Transl. Med.3, 77sr1 (2011).
   PubMed Web of Science ®Google Scholar
• Cummings JL , DoodyR , ClarkC. Disease-modifying therapies for Alzheimer disease challenges to early intervention. Neurology69, 1622–1634 (2007).
   PubMed Web of Science ®Google Scholar
• Budson AE , SolomonPR. New criteria for Alzheimer disease and mild cognitive impairment: implications for the practicing clinician. Neurologist18, 356–363 (2012).
   PubMed Web of Science ®Google Scholar
• Sarter M , BrunoJP. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res. Rev.23(1),28–46 (1997).
   PubMedGoogle Scholar
• Chiou SY , HuangCF , HwangMT , LinG. Comparison of active sites of butyrylcholinesterase and acetylcholinesterase based on inhibition by geometric isomers of benzene-di-N-substituted carbamates. J. Biochem. Mol. Toxicol.23, 303–308 (2009).
   PubMed Web of Science ®Google Scholar
• Ikonomovic MD , KlunkWE , AbrahamsonEEet al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease. Brain131, 1630–1645 (2008).
   PubMed Web of Science ®Google Scholar
• Gulyás B , PavlovaE , KásaPet al. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography. Neurochem. Int.58, 60–68 (2011).
   PubMed Web of Science ®Google Scholar
• Birks J . Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst. Rev.1, CD005593 (2006).
   PubMed Web of Science ®Google Scholar
• Lopez OL , BeckerJT , WahedAS. Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease. J. Neurol. Neurosurg. Psychiatry80, 600–607 (2009).
   PubMed Web of Science ®Google Scholar
• Cummings J , LeeG , NahedP. Alzheimer’s disease drug development pipeline. Alzheimers Dement. (NY)8(1), e12295 (2002).
   Google Scholar
• Greig NH , UtsukiT , IngramDK. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent. Proc. Natl Acad Sci. USA102, 17213–17218 (2005).
   PubMed Web of Science ®Google Scholar
• Darvesh S , HopkinsDA , GeulaC. Neurobiology of butyrylcholinesterase. Nat. Rev. Neurosci.4, 131–138 (2003).
   PubMed Web of Science ®Google Scholar
• Chiara CA , AlessandroGA. Inhibition of cholinesterase-associated aryl acylamidase activity by anticholinesterase agents: focus on drugs potentially effective in Alzheimer’s disease. Biochem. Pharmacol.55(10), 1733–1737 (1998).
   PubMed Web of Science ®Google Scholar
• Giacobini E . Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol. Res.50, 433–440 (2004).
   PubMed Web of Science ®Google Scholar
• Tabet N . Acetylcholinesterase inhibitors for Alzheimer’s disease: anti-inflammatories in acetylcholine clothing!Age. Ageing35, 336–338 (2006).
   PubMed Web of Science ®Google Scholar
• Stanton FM , Hua-YuLW , MatthewCV. Recent advances in acetylcholinesterase inhibitors and reactivators: an update on the patent literature (2012–2015). Expert Opin. Ther. Pat.27(4), 455–476 (2017).
   PubMed Web of Science ®Google Scholar
• Moreta MP , Burgos-AlonsoN , TorrecillaM , Marco-ContellesJ , Bruzos-CidónC. Efficacy of acetylcholinesterase inhibitors on cognitive function in Alzheimer’s disease. Review of reviews. Biomedicines9(11), 1689 (2021).
   PubMed Web of Science ®Google Scholar
• Fabini E , TramarinA , BartoliniM. Combination of human acetylcholinesterase and serum albumin sensing surfaces as highly informative analytical tool for inhibitor screening. J. Pharm. Biomed. Anal.155, 177–184 (2018).
   PubMed Web of Science ®Google Scholar
• Mahmoud Z , SayedHS , MohamedLWet al. Development of new donepezil analogs: synthesis, biological screening and in silico study rational. Med. Chem. Res.31, 1754–1770 (2022).
   Web of Science ®Google Scholar
• Gupta S , FallareroA , JärvinenP. Discovery of dual binding site acetylcholinesterase inhibitors identified by pharmacophore modeling and sequential virtual screening techniques. Bioorg. Med. Chem. Lett.21(4), 1105–1112 (2011).
   PubMed Web of Science ®Google Scholar
• Fancellu G , ChandK , TomásD. Novel tacrine–benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer’s disease. J. Enzyme Inhib. Med. Chem.35(1), 211–226 (2020).
   PubMed Web of Science ®Google Scholar
• Wang X , WangW , LiL , PerryG , LeeHG , ZhuX. Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim. Biophys. Acta1842, 1240 (2014).
   PubMed Web of Science ®Google Scholar
• Gu F , ZhuM , ShiJ , HuY , ZhaoZ. Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice. Neurosci. Lett.440, 44 (2008).
   PubMed Web of Science ®Google Scholar
• Lan JS , XieSS , LiSY , PanLF , WangXB , KongLY. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer’s disease. Bioorg. Med. Chem.22(21), 6089–6104 (2014).
   PubMed Web of Science ®Google Scholar
• Amr AE , AbdallaMM , EssaouySA. Synthesis of some substituted 5H-Furo[3,2-g]chromene and benzofuran sulfonate derivatives as potent anti-HIV agents. Russ. J. Gen. Chem.87, 1591 (2017).
   Web of Science ®Google Scholar
• Cyr L , LangerR , LavigneC. Cell cycle arrest and apoptosis responses of human breast epithelial cells to the synthetic organosulfur compound p-methoxyphenyl p-toluene sulfonate. Anticancer Res.28, 2753 (2008).
   PubMed Web of Science ®Google Scholar
• Nie Q , DuX-G , GengM-Y. Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer’s disease. Acta Pharmacol. Sin.32(5), 545 (2011).
   PubMed Web of Science ®Google Scholar
• Lu C , ZhengP , WangH , WeiY , WangC , HaoS. Design and synthesis of scopoletin sulfonate derivatives as potential insecticidal agents. Molecules38, 530 (2020).
   Google Scholar
• Sahin I , BingolZ , OnurSet al. Enzyme inhibition properties and molecular docking studies of 4-sulfonate containing aryl α-hydroxyphosphonates based hybrid molecules. Chem. Biodivers.19, e202100787 (2022).
   PubMed Web of Science ®Google Scholar
• Pourparizi A , NadriH , NaghshN , EiderAR , PourrajabF. Synthesis of aurone sulfonate derivatives: evaluation of their cholinesterase inhibition, neuroprotective effects, and expression of oxidative stress-related genes. J. Mol. Struct.1294, 136334 (2023).
   Web of Science ®Google Scholar
• Nofal ZM , SrourAM , MansourNM , AbdEl-Karim SS. Synthesis of novel heterocyclic compounds containing thiazolyl-pyrazoline moiety from chalcone derivatives. Polycycl. Aromat. Compd42(8), 5411–5421 (2021).
   Web of Science ®Google Scholar
• Angelova V , KarabeliovV , Andreeva-GatevaPA , TchekalarovaJ. Recent developments of hydrazide/hydrazone derivatives and their analogs as anticonvulsant agents in animal models. Drug Dev. Res.77(7), 379–392 (2016).
   PubMed Web of Science ®Google Scholar
• Dandawate P , KhanE , PadhyeSet al. Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells. Bioorg. Med. Chem. Lett.22, 3104–3108 (2012).
   PubMed Web of Science ®Google Scholar
• Cosar ED , DincelED , DemirarySet al. Anticholinesterase activities of novel indole-based hydrazide-hydrazone derivatives: design, synthesis biological evaluation, molecular docking study and in silico ADME prediction. J. Mol. Struct.1247, 131398 (2022).
   Web of Science ®Google Scholar
• Kratky M , StepankovaS , BrablikovaM , SvrckovaK , SvarcovaM , VinsovaJ. Novel iodinated hydrazide-hydrazones and their analogues as acetyl- and butyrylcholinesterase inhibitors. Curr. Topics Med. Chem.20(23), 2106–2117 (2020).
   PubMed Web of Science ®Google Scholar
• Ibrahim M , AbdulL , AhmadMet al. Sulfonylbis(acylhydrazone) as anticholinesterase inhibitors: synthesis, in vitro biological evaluation and computational studies. J. Mol. Struct.1252, 132215 (2022).
   Web of Science ®Google Scholar
• Danilenko AV , VolovAN , VolovNA , PlatonovaYB , SavilovSV. Design, synthesis and biological evaluation of novel indole-3-carboxylic acid derivatives with antihypertensive activity. Bioorg. Med. Chem. Lett.25(90), 129349 (2023).
   Google Scholar
• Gwaram NS , AliHM , AbdullaMAet al. Synthesis, characterization, x-ray crystallography, acetylcholinesterase inhibition and antioxidant activities of some novel ketone derivatives of gallic hydrazide-derived Schiff bases. Molecules17(3), 2408–2427 (2012).
   PubMed Web of Science ®Google Scholar
• Rami JO , EhsanUM , NafeesaNet al. Pharmacological significance of nitrogen-containing five and six-membered heterocyclic scaffolds as potent cholinesterase inhibitors for drug discovery. Process Biochem.120, 250–259 (2022).
   Google Scholar
• Obaid RJ , NaeemN , MughalEUet al. Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase. RSC Adv.12(31), 19764–19855 (2022).
   PubMed Web of Science ®Google Scholar
• Reem IA , EhsanUM , NafeesaNet al. Flavone-based hydrazones as new tyrosinase inhibitors: synthetic imines with emerging biological potential, SAR, molecular docking and drug-likeness studies. J. Mol. Struct.1251, 131933 (2022).
   Web of Science ®Google Scholar
• Srour A , DawoodD , KhalilM , NofalZ. Synthesis and 2D-QSAR study of dispiropyrrolodinyl-oxindole based alkaloids as cholinesterase inhibitors. Bioorg. Chem.83, 226–234 (2018).
   PubMed Web of Science ®Google Scholar
• Copeland RA . Evaluation of Enzyme Inhibitors in Drug Discovery: a Guide for Medicinal Chemists and Pharmacologists (Second Edition).John Wiley & Sons, Inc., NJ, USA (2005).
   Google Scholar
• Nicolet Y , LockridgeO , MassonP , Fontecilla-CampsJC , NachonF. Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J. Biol. Chem.278(42), 41141–41147 (2003).
   PubMed Web of Science ®Google Scholar
• Garrett M , MorrisRH , WilliamLet al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem.30(16), 2785–2791 (2009).
   PubMed Web of Science ®Google Scholar
• SwissADME website. www.swissadme.ch (Accessed 20June2023).
   Google Scholar
• Daina A , MichielinO , ZoeteV. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep.7, 42717 (2017).
   PubMed Web of Science ®Google Scholar
• Bowers KJ , ChowDE , XuHet al. Molecular dynamics – scalable algorithms for molecular dynamics simulations on commodity clusters. Presented at: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing-SC’06.Tampa, FL, USA (11–17 November 2006).
   Google Scholar
• Smart Encoders. www.smartencoders.net (Accessed 10August2023).
   Google Scholar
• Shivakumar D , WilliamsJ , WuY , DammW , ShelleyJ , ShermanW. Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field. J. Chem. Theory Comput.6, 1509–1519 (2010).
   PubMed Web of Science ®Google Scholar
• Sugimoto H , OguraH , AraiY , LimuraY , YamanishiY. Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor. Jpn J. Pharmacol.89(1), 7–20 (2002).
   PubMedGoogle Scholar
• Shin CY , KimHS , ChaKHet al. The effects of donepezil, an acetylcholinesterase inhibitor, on impaired learning and memory in rodents. Biomol. Ther. (Seoul)26(3), 274–281 (2018).
   PubMed Web of Science ®Google Scholar
• Cheung J , RudolphMJ , BurshteynFet al. Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J. Med. Chem.55, 10282–10286 (2012).
   PubMed Web of Science ®Google Scholar
• D Biovia , HBerman , JWestbrook , ZFeng , GGilliland , TBhatet al. Dassault Systèmes BIOVIA, Discovery Studio Visualizer, v. 17.2, San Diego. Dassault Systèmes10(2000), 0021–9991 (2016).
   Google Scholar